Test-retest reliability and reproducibility of short-echo-time spectroscopic imaging of human brain at 3T

Magnetic Resonance in Medicine

Volumn 66, Issue 2, 2011, Pages 324-332

  Gasparovic, Charles ^a,b   Bedrick, Edward J ^c   Mayer, Andrew R ^a,c   Yeo, Ronald A ^b   Chen, Hongji ^c   Damaraju, Eswar ^a   Calhoun, Vince D ^a,b   Jung, Rex E ^a,c  

^a MIND RESEARCH NETWORK   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

brain; magnetic resonance spectroscopy; reproducibility

Indexed keywords

AMINO ACIDS; BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; NEUROMUSCULAR REHABILITATION; RELIABILITY;

COEFFICIENT OF VARIATION; HIGH REPRODUCIBILITY; INTRACLASS CORRELATION COEFFICIENTS; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; PARTIAL VOLUME CORRECTION; REPRODUCIBILITIES; SPECTROSCOPIC IMAGING; TEST-RETEST RELIABILITY;

MAGNETIC RESONANCE;

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; LATERAL BRAIN VENTRICLE; MALE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; TEST RETEST RELIABILITY; WHITE MATTER;

EID: 79960312453     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22858     Document Type: Article

References (31)

1. Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S,. A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 2004; 22: 523-528. (Pubitemid 38534668)
2. Di Costanzo A, Trojsi F, Tosetti M, Schirmer T, Lechner SM, Popolizio T, Scarabino T,. Proton MR spectroscopy of the brain at 3 T: an update. Eur Radiol 2007; 17: 1651-1662. (Pubitemid 46909653)
3. Cianfoni A, Niku S, Imbesi SG,. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 2007; 28: 272-277. (Pubitemid 46281044)
4. Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D,. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain; 133: 2603-2611.
5. Li Y, Chen AP, Crane JC, Chang SM, Vigneron DB, Nelson SJ,. Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T. Magn Reson Med 2007; 58: 886-892. (Pubitemid 350074355)
6. Chawla S, Wang S, Wolf RL, Woo JH, Wang J, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H,. Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol 2007; 28: 1683-1689. (Pubitemid 47598140)
7. Gasparovic C, Yeo R, Mannell M, Ling J, Elgie R, Phillips J, Doezema D, Mayer AR,. Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study. J Neurotrauma 2009; 26: 1635-1643.
8. Gonen O, Gruber S, Li BS, Mlynarik V, Moser E,. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 2001; 22: 1727-1731. (Pubitemid 32999583)
9. Schubert F, Gallinat J, Seifert F, Rinneberg H,. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004; 21: 1762-1771. (Pubitemid 38446596)
10. Mayer D, Spielman DM,. Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy. Magn Reson Med 2005; 54: 439-442. (Pubitemid 41033562)
11. Mullins PG, Chen H, Xu J, Caprihan A, Gasparovic C,. Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn Reson Med 2008; 60: 964-969.
12. Tedeschi G, Bertolino A, Campbell G, Barnett AS, Duyn JH, Jacob PK, Moonen CT, Alger JR, Di Chiro G,. Reproducibility of proton MR spectroscopic imaging findings. AJNR Am J Neuroradiol 1996; 17: 1871-1879. (Pubitemid 26384826)
13. Charles HC, Lazeyras F, Tupler LA, Krishnan KR,. Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain. Magn Reson Med 1996; 35: 606-610. (Pubitemid 26112253)
14. Chard DT, McLean MA, Parker GJ, MacManus DG, Miller DH,. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2002; 15: 219-225. (Pubitemid 34112915)
15. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O,. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002; 47: 439-446. (Pubitemid 34193997)
16. Zhu XP, Young K, Ebel A, Soher BJ, Kaiser L, Matson G, Weiner WM, Schuff N,. Robust analysis of short echo time (1)H MRSI of human brain. Magn Reson Med 2006; 55: 706-711. (Pubitemid 43352573)
17. Langer DL, Rakaric P, Kirilova A, Jaffray DA, Damyanovich AZ,. Assessment of metabolite quantitation reproducibility in serial 3D-(1)H-MR spectroscopic imaging of human brain using stereotactic repositioning. Magn Reson Med 2007; 58: 666-673. (Pubitemid 47556872)
18. Ratai EM, Hancu I, Blezek DJ, Turk KW, Halpern E, Gonzalez RG,. Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements. J Magn Reson Imaging 2008; 27: 1188-1193. (Pubitemid 351614635)
19. Gu M, Kim DH, Mayer D, Sullivan EV, Pfefferbaum A, Spielman DM,. Reproducibility study of whole-brain 1H spectroscopic imaging with automated quantification. Magn Reson Med 2008; 60: 542-547.
20. Maudsley AA, Domenig C, Sheriff S,. Reproducibility of serial whole-brain MR spectroscopic imaging. NMR Biomed; 23: 251-256.
21. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, Posse S, Jung RE, Morrison LA,. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006; 55: 1219-1226. (Pubitemid 43856758)
22. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679. (Pubitemid 23360802)
23. Ashburner J, Friston KJ,. Unified segmentation. Neuroimage 2005; 26: 839-851. (Pubitemid 40825026)
24. Gasparovic C, Neeb H, Feis DL, Damaraju E, Chen H, Doty MJ, South DM, Mullins PG, Bockholt HJ, Shah NJ,. Quantitative spectroscopic imaging with in situ measurements of tissue water T1, T2, and density. Magn Reson Med 2009; 62: 583-590.
25. Vymazal J, Righini A, Brooks RA, Canesi M, Mariani C, Leonardi M, Pezzoli G,. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999; 211: 489-495. (Pubitemid 29206821)
26. Kreis R, Ernst T, Ross BD,. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424-437. (Pubitemid 23300070)
27. Mlynarik V, Gruber S, Moser E,. Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 2001; 14: 325-331. (Pubitemid 32782846)
28. Kreis R,. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004; 17: 361-381. (Pubitemid 39335175)
29. Shrout PE, Fleiss JL,. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
30. Schirmer T, Auer DP,. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000; 13: 28-36. (Pubitemid 30136999)
31. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C,. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med 2004; 51: 904-912. (Pubitemid 38580602)